2 results
Approved WMOCompleted
The objective of this project is to assess the applicability of [18F]PK209 for in vivo imaging of the NMDA receptor.
Approved WMOCompleted
This study aims to test the hypothesis that zandelisib in combination with rituximab has better clinical activity and risk/benefit profile compared to standard 2nd line immunochemotherapy (R-CHOP/R-B) in subjects with relapsed FL or MZL. Primary…